Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Prognostic Studies

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

Leukemia volume 15, pages 1161–1164 (2001)Cite this article

Abstract

CD56 antigen, a 200–220 kDa cell surface glycoprotein, identified as an isoform of the neural adhesion molecules (NCAM), has been found frequently expressed in several lympho–hematopoietic neoplasms including acute myeloid leukemias (AML). In fact, in these latter diseases it has been reported that the presence of CD56 antigen on the blasts of AML patients with t(8;21) (q22;q22), and in those with M3 subtype, identifies a subgroup of patients with a more unfavorable prognosis. On the basis of these findings, we evaluated in 152 newly diagnosed AML patients CD56 surface expression, and results were correlated with morphology, immunophenotype, cytogenetic pattern and clinical outcome. CD56 antigen was recorded in 37 out of 152 cases (24%) and particularly in those with M2 and M5 cytotypes. Moreover, CD56 expression was significantly associated with P-glycoprotein (PGP) hyperexpression (P = 0.007), unfavorable cytogenetic abnormalities (P = 0.008) and with a reduced probability of achieving complete remission (CR) (36% vs 68%) (P = 0.035) as well as with a shorter survival (6 vs 12 months) (P = 0.032). In conclusion, CD56 antigenic expression on AML cells represents an important adverse prognostic factor and therefore its presence should be regularly investigated for a better prognostic assessment of AML patients at diagnosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McCulloch EA, Kellecher CA, Miyauchi J, Wang C, Cheng GYN, Minden MD, Curtis JE . Heterogeneity in acute myeloblastic leukemia Leukemia 1998 2: 38s

    Google Scholar 

  2. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of acute myeloid leukemias Br J Haematol 1976 33: 451–458

    Article  Google Scholar 

  3. Drexler HG . Classification of acute myeloid leukemia. A comparison of FAB and immunophenotyping Leukemia 1987 1: 697–705

    CAS  PubMed  Google Scholar 

  4. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa AM, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J . Prognostic significance of karyotype in de novo adult acute myeloid leukemia Leukemia 1995 9: 1491–1498

    CAS  PubMed  Google Scholar 

  5. Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrozek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD . Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry Leukemia 1998 12: 317–325

    Article  CAS  PubMed  Google Scholar 

  6. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Otha C, Tsutani H, Oguma S . Clinical importance of CD7 expression in acute myelocytic leukemia Blood 1993 81: 2399–2405

    CAS  PubMed  Google Scholar 

  7. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G . Prognostic value of cell marker analysis in de novo acute myeloid leukemia Leukemia 1994 8: 288–394

    Google Scholar 

  8. Lauria F, Raspadori D, Ventura MA, Rondelli D, Tura S . CD7 expression does not affect the prognosis in acute myeloid leukemia Blood 1994 10: 3097–3098

    Google Scholar 

  9. Myint H, Lucie NP . The prognostic significance of the CD34 antigen in acute myeloid leukemia Leuk Lymphoma 1992 7: 425–429

    Article  CAS  PubMed  Google Scholar 

  10. Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, de Vivo A, Tura S . Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis in 141 cases Leuk Res 1997 21: 603–607

    Article  CAS  PubMed  Google Scholar 

  11. Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G, Forconi F, Tura S . High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate Leukemia 1997 11: 2075–2078

    Article  CAS  PubMed  Google Scholar 

  12. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH . The relationship of CD16 (Leu11) and Leu19 (NKH-1) antigen expression of human peripheral blood NK cells and cytotoxic lymphocytes J Immunol 1986 136: 4480–4483

    CAS  PubMed  Google Scholar 

  13. Griffin JD, Hercend T, Beveridge R, Schlossmann SF . Characterization of an antigen expressed by human natural killer cells J Immunol 1983 130: 2947–2951

    CAS  PubMed  Google Scholar 

  14. Lanier LL, Testi R, Bindi J, Phillips JH . Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule J Exp Med 1989 169: 2233–2238

    Article  CAS  PubMed  Google Scholar 

  15. Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M, Bernengo MG . CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease Br J Dermatol 1997 137: 966–971

    Article  CAS  PubMed  Google Scholar 

  16. Muroi K, Omine K, Kuribara R, Uchida M, Izumi T, Hatake K, Miura Y . CD56 expression in B-cell lymphoma Leuk Res 1998 22: 201–202

    Article  CAS  PubMed  Google Scholar 

  17. Ikushima S, Yoshihara T, Misawa S, Morioka Y, Hibi S, Imashuku S . Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias Int J Haematol 1991 54: 395–403

    CAS  Google Scholar 

  18. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morisima Y, Takagashi T, Saito H, Ueda R, Nakamura S . CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity Blood 1997 90: 2417–2428

    CAS  PubMed  Google Scholar 

  19. Hatano Y, Miura I, Horiuchi T, Hoshi N, Nanjou H, Masuda H, Miura AB . Cerebellar myeloblastoma formation in CD7-positive, neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia (M1) Ann Hematol 1997 75: 125–128

    Article  CAS  PubMed  Google Scholar 

  20. Murase T, Suzuki R, Tashiro K, Moishima Y, Nakamura S . Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor Int J Hematol 1999 69: 89–91

    CAS  PubMed  Google Scholar 

  21. Reuss-Borst MA, Steinke B, Waller HD, Buhring HJ, Muller CA . Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia Ann Haematol 1992 64: 78–82

    Article  CAS  Google Scholar 

  22. Dunphy CH, Gregowicz AJ, Rodriguez G . Natural killer cell acute leukemia with myeloid antigen expression. A previously undescribed form of acute leukemia Hematopathology 1995 104: 212–215

    CAS  Google Scholar 

  23. Baer Mr, Stewart CC, Lawrence D, Arthur DC, Byrd JC, Davey FR, Schiffer CA, Bloomfield CD . Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21) (q22;q22) Blood 1997 90: 1643–1648

    CAS  PubMed  Google Scholar 

  24. Daniels JT, Davis BJ, Houde-McGrail L, Byrd JC . Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker? Br J Haematol 1999 107: 371–383

    Article  Google Scholar 

  25. Murray CK, Estey E, Paietta E, Howard RS, Edenfield W J, Pierce S, Mann KP, Bolan C, Byrd JC . CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol 1999 17: 293–297

    Article  CAS  PubMed  Google Scholar 

  26. Lauria F, Raspadori D, Ventura MA, Rondelli D, Testoni N, Tosi P, Michieli M, Damiani D, Motta MR, Tura S . The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance Stem Cells 1995 13: 428–434

    Article  CAS  PubMed  Google Scholar 

  27. Michieli M, Damiani D, Geromin A, Michelutti A, Fanin R, Raspadori D, Russo D, Visani G, Dinota A, Pileri S, Tsuruo T, Grandi M, Baccarani M, Tura S . Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia Eur J Haematol 1992 48: 87–92

    Article  CAS  PubMed  Google Scholar 

  28. Harnden DG, Klinger HP (eds) . An International System for Human Cytogenetic Nomenclature Karger: Basel 1985

    Google Scholar 

  29. Leith CP, Kopecky KJ, Godwin JE, McConnell T, Slovak M, Chen IM, Head DR, Appelbaum F, Willman CL . Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups Blood 1997 89: 3323–3328

    CAS  PubMed  Google Scholar 

  30. Kaplan EL, Meier P . Non parametric estimation for incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  31. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Br J Cancer 1977 35: 1–39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Cox DR . The Analysis of Binary Data Chapman & Hall: London 1970

    Google Scholar 

  33. van Camp B, Durie BGM, Spier C, de Wuaele M, van Riet I, Vela E, Frutiger Y, Richter L, Grogan TM . Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu 19) Blood 1990 76: 377–382

    CAS  PubMed  Google Scholar 

  34. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreef M . Subpopulations of normal peripheral blood marrow cells express a functional multidrug resistant phenotype Blood 1992 80: 2729–2732

    CAS  PubMed  Google Scholar 

  35. Klimecki WT, Futscher BW, Grogan TM, Dalton WS . P-glycoprotein expression and function in circulating blood cells from normal volunteers Blood 1994 83: 2451–2458

    CAS  PubMed  Google Scholar 

  36. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH . Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56) Leukemia 1994 8: 823–826

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by MURST ex 40% 1998.

Author information

Authors and Affiliations

  1. Department of Hematology, University of Siena, Italy

    D Raspadori, M Lenoci, G Nardi, C Sestigiani, C Mariotti, S Birtolo, M Tozzi & F Lauria

  2. Chair of Hematology, University of Udine, Italy

    D Damiani

  3. Institute of Hematology and Clinical Oncology ‘Seràgnoli’, University of Bologna, Italy

    D Rondelli & N Testoni

Authors
  1. D Raspadori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Damiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Lenoci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Rondelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Testoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Nardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Sestigiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C Mariotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Birtolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Tozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F Lauria
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raspadori, D., Damiani, D., Lenoci, M. et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 15, 1161–1164 (2001). https://doi.org/10.1038/sj.leu.2402174

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402174

Keywords

This article is cited by

Search

Advanced search

Quick links